Lilly to present diabetes and obesity drug data at EASD 2026
Eli Lilly and Company (NYSE: LLY) will present clinical data from multiple drug programs at the 62nd Annual Meeting of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
